106 related articles for article (PubMed ID: 32040102)
1. An integrated microfluidic system for rapid, automatic and high-throughput staining of clinical tissue samples for diagnosis of ovarian cancer.
Huang SP; Chuang YJ; Lee WB; Tsai YC; Lin CN; Hsu KF; Lee GB
Lab Chip; 2020 Mar; 20(6):1103-1109. PubMed ID: 32040102
[TBL] [Abstract][Full Text] [Related]
2. Microfluidic-based immunohistochemistry for breast cancer diagnosis: a comparative clinical study.
Aimi F; Procopio MG; Alvarez Flores MT; Brouland JP; Piazzon N; Brajkovic S; Dupouy DG; Gijs M; de Leval L
Virchows Arch; 2019 Sep; 475(3):313-323. PubMed ID: 31267199
[TBL] [Abstract][Full Text] [Related]
3. Optimization of aptamer selection on an automated microfluidic system with cancer tissues.
Lin CS; Tsai YC; Hsu KF; Lee GB
Lab Chip; 2021 Feb; 21(4):725-734. PubMed ID: 33480930
[TBL] [Abstract][Full Text] [Related]
4. Microfluidic-Based Immunohistochemistry Combined With Next-Generation Sequencing on Diagnostic Tissue Sections for Detection of Tumoral BRAF V600E Mutation.
Leblond AL; Rechsteiner M; Jones A; Brajkovic S; Dupouy D; Soltermann A
Am J Clin Pathol; 2019 Jun; 152(1):59-73. PubMed ID: 31065676
[TBL] [Abstract][Full Text] [Related]
5. Cancer cell-specific oligopeptides selected by an integrated microfluidic system from a phage display library for ovarian cancer diagnosis.
Wang CH; Weng CH; Che YJ; Wang K; Lee GB
Theranostics; 2015; 5(4):431-42. PubMed ID: 25699101
[TBL] [Abstract][Full Text] [Related]
6. A fluorescence in situ hybridization (FISH) microfluidic platform for detection of HER2 amplification in cancer cells.
Kao KJ; Tai CH; Chang WH; Yeh TS; Chen TC; Lee GB
Biosens Bioelectron; 2015 Jul; 69():272-9. PubMed ID: 25770459
[TBL] [Abstract][Full Text] [Related]
7. Tissue lithography: Microscale dewaxing to enable retrospective studies on formalin-fixed paraffin-embedded (FFPE) tissue sections.
Cors JF; Kashyap A; Fomitcheva Khartchenko A; Schraml P; Kaigala GV
PLoS One; 2017; 12(5):e0176691. PubMed ID: 28493979
[TBL] [Abstract][Full Text] [Related]
8. An automated microfluidic system for selection of aptamer probes against ovarian cancer tissues.
Liu WT; Lee WB; Tsai YC; Chuang YJ; Hsu KF; Lee GB
Biomicrofluidics; 2019 Jan; 13(1):014114. PubMed ID: 30867884
[TBL] [Abstract][Full Text] [Related]
9. Microfluidics for rapid detection of isocitrate dehydrogenase 1 mutation for intraoperative application.
Aibaidula A; Zhao W; Wu JS; Chen H; Shi ZF; Zheng LL; Mao Y; Zhou LF; Sui GD
J Neurosurg; 2016 Jun; 124(6):1611-8. PubMed ID: 26544771
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemistry Microarrays.
Li H; Brewer G; Ongo G; Normandeau F; Omeroglu A; Juncker D
Anal Chem; 2017 Sep; 89(17):8620-8625. PubMed ID: 28763195
[TBL] [Abstract][Full Text] [Related]
11. Combining fluorescence-based image segmentation and automated microfluidics for ultrafast cell-by-cell assessment of biomarkers for HER2-type breast carcinoma.
Migliozzi D; Nguyen HT; Gijs MAM
J Biomed Opt; 2018 Nov; 24(2):1-8. PubMed ID: 30484294
[TBL] [Abstract][Full Text] [Related]
12. Microfluidic on-chip immunohistochemistry directly from a paraffin-embedded section.
Cho CH; Kwon S; Kim S; Hong Y; Kim P; Lee ES; Park JK
Biomicrofluidics; 2018 Jul; 12(4):044110. PubMed ID: 30079122
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer diagnostics using microfluidic multiplexed immunohistochemistry.
Kim MS; Kwon S; Park JK
Methods Mol Biol; 2013; 949():349-64. PubMed ID: 23329453
[TBL] [Abstract][Full Text] [Related]
14. A multiplexable, microfluidic platform for the rapid quantitation of a biomarker panel for early ovarian cancer detection at the point-of-care.
Shadfan BH; Simmons AR; Simmons GW; Ho A; Wong J; Lu KH; Bast RC; McDevitt JT
Cancer Prev Res (Phila); 2015 Jan; 8(1):37-48. PubMed ID: 25388014
[TBL] [Abstract][Full Text] [Related]
15. A Microfluidic Immunostaining System Enables Quality Assured and Standardized Immunohistochemical Biomarker Analysis.
Kwon S; Cho CH; Kwon Y; Lee ES; Park JK
Sci Rep; 2017 Apr; 7():45968. PubMed ID: 28378835
[TBL] [Abstract][Full Text] [Related]
16. Digital immunohistochemistry platform for the staining variation monitoring based on integration of image and statistical analyses with laboratory information system.
Laurinaviciene A; Plancoulaine B; Baltrusaityte I; Meskauskas R; Besusparis J; Lesciute-Krilaviciene D; Raudeliunas D; Iqbal Y; Herlin P; Laurinavicius A
Diagn Pathol; 2014; 9 Suppl 1(Suppl 1):S10. PubMed ID: 25565007
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Diagnostic Utility of a High-Risk Human Papillomavirus PCR Test on Formalin-Fixed, Paraffin-Embedded Head and Neck Tumor Tissues.
Huho AN; Yadak N; Bocklage TJ; Yang S
J Mol Diagn; 2018 Mar; 20(2):232-239. PubMed ID: 29277636
[TBL] [Abstract][Full Text] [Related]
18. Integration of computer-aided automated analysis algorithms in the development and validation of immunohistochemistry biomarkers in ovarian cancer.
Gentles L; Howarth R; Lee WJ; Sharma-Saha S; Ralte A; Curtin N; Drew Y; O'Donnell RL
J Clin Pathol; 2021 Jul; 74(7):469-474. PubMed ID: 33214200
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.
McCluggage WG; Young RH
Semin Diagn Pathol; 2005 Feb; 22(1):3-32. PubMed ID: 16512597
[TBL] [Abstract][Full Text] [Related]
20. Quantitative proteomic profiling of breast cancers using a multiplexed microfluidic platform for immunohistochemistry and immunocytochemistry.
Kim MS; Kwon S; Kim T; Lee ES; Park JK
Biomaterials; 2011 Feb; 32(5):1396-403. PubMed ID: 21093044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
